170 related articles for article (PubMed ID: 28190755)
21. Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine.
Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Asakura M; Matsumura R; Itoh M
Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():64-9. PubMed ID: 8750798
[TBL] [Abstract][Full Text] [Related]
22. Molecular determinants responsible for sedative and non-sedative properties of histamine H₁-receptor antagonists.
Uesawa Y; Hishinuma S; Shoji M
J Pharmacol Sci; 2014; 124(2):160-8. PubMed ID: 24476926
[TBL] [Abstract][Full Text] [Related]
23. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
[TBL] [Abstract][Full Text] [Related]
24. [Molecular imaging of histamine receptors in the human brain].
Tashiro M; Yanai K
Brain Nerve; 2007 Mar; 59(3):221-31. PubMed ID: 17370648
[TBL] [Abstract][Full Text] [Related]
25. Cerebral histamine H1 receptor binding potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine.
Senda M; Kubo N; Adachi K; Ikari Y; Matsumoto K; Shimizu K; Tominaga H
J Nucl Med; 2009 Jun; 50(6):887-92. PubMed ID: 19443589
[TBL] [Abstract][Full Text] [Related]
26. Effects of first- and second-generation histamine-H1-receptor antagonists on the pentobarbital-induced loss of the righting reflex in streptozotocin-induced diabetic mice.
Kamei J; Hirano S; Miyata S; Saitoh A; Onodera K
J Pharmacol Sci; 2005 Feb; 97(2):266-72. PubMed ID: 15699576
[TBL] [Abstract][Full Text] [Related]
27. P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists.
Chen C; Hanson E; Watson JW; Lee JS
Drug Metab Dispos; 2003 Mar; 31(3):312-8. PubMed ID: 12584158
[TBL] [Abstract][Full Text] [Related]
28. Central effect of the potent long-acting H1-antihistamine levocabastine.
Tasaka K; Kamei C; Tsujimoto S; Yoshida T; Aoki I
Arzneimittelforschung; 1990 Dec; 40(12):1295-9. PubMed ID: 1982750
[TBL] [Abstract][Full Text] [Related]
29. Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.
Rose C; Quach TT; Llorens C; Schwartz JC
Arzneimittelforschung; 1982; 32(9a):1171-3. PubMed ID: 6129863
[TBL] [Abstract][Full Text] [Related]
30. Olopatadine suppresses the migration of THP-1 monocytes induced by S100A12 protein.
Kishimoto K; Kaneko S; Ohmori K; Tamura T; Hasegawa K
Mediators Inflamm; 2006; 2006(1):42726. PubMed ID: 16864903
[TBL] [Abstract][Full Text] [Related]
31. The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H
Bosma R; van den Bor J; Vischer HF; Labeaga L; Leurs R
Eur J Pharmacol; 2018 Nov; 838():107-111. PubMed ID: 30201377
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate.
Kato M; Nishida A; Aga Y; Kita J; Kudo Y; Narita H; Endo T
Arzneimittelforschung; 1997 Oct; 47(10):1116-24. PubMed ID: 9368705
[TBL] [Abstract][Full Text] [Related]
33. Cardiotoxic potential and CNS effects of first-generation antihistamines.
Taglialatela M; Timmerman H; Annunziato L
Trends Pharmacol Sci; 2000 Feb; 21(2):52-6. PubMed ID: 10664607
[No Abstract] [Full Text] [Related]
34. Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.
Hiraoka K; Tashiro M; Grobosch T; Maurer M; Oda K; Toyohara J; Ishii K; Ishiwata K; Yanai K
Expert Opin Drug Saf; 2015 Feb; 14(2):199-206. PubMed ID: 25466429
[TBL] [Abstract][Full Text] [Related]
35. Histamine H₁ receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers.
Sato H; Ito C; Tashiro M; Hiraoka K; Shibuya K; Funaki Y; Iwata R; Matsuoka H; Yanai K
Psychopharmacology (Berl); 2013 Nov; 230(2):227-34. PubMed ID: 23728612
[TBL] [Abstract][Full Text] [Related]
36. Central nervous system effects of H1-receptor antagonists in the elderly.
Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
[TBL] [Abstract][Full Text] [Related]
37. Effects of second-generation histamine H1 receptor antagonists on the sleep-wakefulness cycle in rats.
Shigemoto Y; Shinomiya K; Mio M; Azuma N; Kamei C
Eur J Pharmacol; 2004 Jun; 494(2-3):161-5. PubMed ID: 15212970
[TBL] [Abstract][Full Text] [Related]
38. The noncompetitive antagonism of histamine H1 receptors expressed in Chinese hamster ovary cells by olopatadine hydrochloride: its potency and molecular mechanism.
Matsumoto Y; Funahashi J; Mori K; Hayashi K; Yano H
Pharmacology; 2008; 81(3):266-74. PubMed ID: 18268402
[TBL] [Abstract][Full Text] [Related]
39. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
[TBL] [Abstract][Full Text] [Related]
40. Effects of histamine-1 receptor antagonism on leukocyte-independent plasma extravasation during endotoxemia.
Walther A; Jäger M; Secchi A; Schmidt W; Bach A; Martin E; Schmidt H
J Crit Care; 2001 Mar; 16(1):24-31. PubMed ID: 11230721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
